Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sipai Health Technology CoFRA:AX1 -2.80%64 Net Debt Paydown Yield % is 2.85% as of Aug. 20, 2026, which is 595% above its 10-year median of 0.41. GuruFocus rates FRA:AX1 with a GF Score™ of 64/100 and a GF Value™ of €0.22. The stock has 5 warning signs investors should review. Among 105 Medical Distribution companies, Sipai Health Technology Co ranks better than 67.62% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Sipai Health Technology Co's Net Debt Paydown Yield % was 2.85%.
Sipai Health Technology Co (FRA:AX1) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co Net Debt Paydown Yield % Chart
FRA:AX1 vs MCK, COR, CAH: Net Debt Paydown Yield % Comparison
For the Medical Distribution subindustry, Sipai Health Technology Co's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co Net Debt Paydown Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 2.85% mean?
Sipai Health Technology Co (FRA:AX1) has a Net Debt Paydown Yield % of 2.85% as of Aug. 20, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Sipai Health Technology Co and its competitors. This is 595% above median its historical median of 0.41. Over the past decade, Sipai Health Technology Co's Net Debt Paydown Yield % has ranged from 0.11 to 2.85. According to the industry distribution chart, Sipai Health Technology Co ranks #34 out of 105 companies in the Medical Distribution industry, placing it in the top 32.4%.
Is Sipai Health Technology Co's Net Debt Paydown Yield % too high?
Sipai Health Technology Co's current Net Debt Paydown Yield % of 2.85% is 595% above median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 2.85. The Medical Distribution industry median Net Debt Paydown Yield % is 0.10. Sipai Health Technology Co's value of 2.85% is 2750% above this industry median. Based on the distribution chart, Sipai Health Technology Co ranks #34 out of 105 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sipai Health Technology Co has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's Net Debt Paydown Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #34 out of 105 companies for Net Debt Paydown Yield %. This puts Sipai Health Technology Co in the upper half of its industry. The industry median Net Debt Paydown Yield % is 0.10. Sipai Health Technology Co's value of 2.85% is 2750% above this benchmark. Historically, Sipai Health Technology Co's own Net Debt Paydown Yield % has ranged from 0.11 to 2.85 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.10, Sipai Health Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Medical Distribution company?
The median Net Debt Paydown Yield % among Medical Distribution companies is 0.10, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sipai Health Technology Co's current Net Debt Paydown Yield % of 2.85% is 2750% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median Net Debt Paydown Yield % is 0.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current Net Debt Paydown Yield % is 2.85%, which is 595% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Sipai Health Technology Co (FRA:AX1) has a current Net Debt Paydown Yield % of 2.85%. The stock's GF Value™ is €0.22, compared to a current price of €0.14 — trading 36.8% below its estimated fair value. The current Net Debt Paydown Yield % is 2.85%, which is 595% above median its 10-year median of 0.41 and 2750% above the Medical Distribution industry median of 0.10. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Sipai Health Technology Co (FRA:AX1), the current Net Debt Paydown Yield % is 2.85% as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of €0.14 is trading 36.8% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:AX1:
Net Debt Paydown Yield %: 2.85% (595% above median its 10-year median of 0.41)
GF Value™: €0.22 vs. price of €0.14 (36.8% below fair value)
Industry Position: 2750% above the Medical Distribution median (#34 of 105)
No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for FRA:AX1
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AX1 has been successfully added to your 
